Used in neuroscience and Alzheimer’s disease research to quantitatively measure levels of amyloid precursor protein (APP) in mouse tissue samples, cell lysates, or biological fluids. The kit enables researchers to study APP expression and processing in experimental models, helping to investigate the mechanisms of amyloid-beta plaque formation, a hallmark of Alzheimer's pathology. It is commonly applied in preclinical studies evaluating potential therapeutic interventions targeting APP metabolism or neurodegeneration. The assay supports high-throughput screening and provides sensitive and specific detection, making it valuable for longitudinal studies in transgenic mouse models of dementia.